Lisata Therapeutics Ownership | Who Owns Lisata Therapeutics?

Overview RevenueFinancials Chart Transcripts

Lisata Therapeutics Ownership Summary

Lisata Therapeutics is owned by 7.84% institutional investors, 19.68% insiders, and 72.49% retail investors. Vanguard group is the largest institutional shareholder, holding 3.10% of LSTA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.12% of its assets in Lisata Therapeutics shares.

LSTA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Lisata Therapeutics	7.84%	19.68%	72.49%
Sector	Healthcare Stocks	232.86%	10.65%	-143.51%
Industry	Biotech Stocks	382.13%	10.41%	-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	270.91K	3.10%	$503.89K
Renaissance	123.72K	1.42%	$230.11K
Bml capital management	73.35K	0.84%	$136.43K
Geode capital management	64.43K	0.74%	$119.86K
Blackrock funding, inc. /de	54.86K	0.63%	$102.03K
State street	14.35K	0.17%	$37.59K
Dimensional fund advisors lp	14.25K	0.16%	$26.51K
Cerity partners	12.18K	0.14%	$49.08K
Xtx topco	11.11K	0.13%	$29.11K
Northern trust	10.27K	0.12%	$26.90K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bml capital management	73.35K	0.12%	$136.43K
Founders capital management	1.67K	0.00%	$8.35K
Connective capital management	1.02K	0.00%	$2.66K
Xtx topco	11.11K	0.00%	$29.11K
International assets investment management	5.00K	0.00%	$9.30K
Renaissance	123.72K	0.00%	$230.11K
Tower research capital llc (trc)	1.67K	0.00%	$4.38K
Cerity partners	12.18K	0.00%	$49.08K
Advisor group	-	-	-
Barclays	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Xtx topco	11.11K	0.00%	11.11K
Renaissance	123.72K	0.00%	7.09K
International assets investment management	5.00K	0.00%	5.00K
Geode capital management	64.43K	-	1.17K
Connective capital management	1.02K	0.00%	1.02K

Top Sellers

Holder	Shares	% Assets	Change
Ground swell capital	-	-	-38.99K
Bml capital management	73.35K	0.12%	-36.49K
Dimensional fund advisors lp	14.25K	-	-6.69K
Morgan stanley	75.00	-	-133.00
Sbi securities	7.00	-	-133.00

New Positions

Holder	Shares	% Assets	Change	Value
Xtx topco	11.11K	0.00%	11.11K	$29.11K
International assets investment management	5.00K	0.00%	5.00K	$9.30K
Connective capital management	1.02K	0.00%	1.02K	$2.66K
Citigroup	1.00	-	1.00	$2.00

Sold Out

Holder	Change
Advisor group	-1.00
Wells fargo & company/mn	-1.00
Loring wolcott & coolidge fiduciary advisors llp/ma	-2.00
Barclays	-4.00
Raymond james financial	-6.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	18	-18.18%	684,695	-9.09%	7	10.23%	8	-20.00%	6	50.00%
Sep 30, 2025	21	5.00%	752,137	-3.88%	8	10.57%	9	12.50%	4	33.33%
Jun 30, 2025	20	-9.09%	782,490	-0.11%	9	10.96%	8	-20.00%	3	-40.00%
Mar 31, 2025	22	15.79%	783,376	-0.29%	9	10.23%	10	66.67%	5	150.00%
Dec 31, 2024	19	-	785,678	2.42%	9	11.10%	6	-25.00%	2	-50.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	191.37K	2.12%	-
Vanguard Institutional Extnd Mkt Idx Tr	80.44K	0.89%	16.85K
Fidelity Extended Market Index	41.22K	0.46%	3.23K
Pender Alternative Arbitrage Plus F	40.50K	0.45%	40.50K
Fidelity Series Total Market Index	9.23K	0.10%	-
Northern Trust Extended Eq Market Idx	7.14K	0.08%	-
NT Ext Equity Mkt Idx Fd - L	7.14K	0.08%	-
Pender Alternative Arbitrage Cl FF	7.00K	0.08%	7.00K
Spartan Extended Market Index Pool F	6.77K	0.07%	-
Spartan Total Market Index Pool G	4.64K	0.05%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 08, 2021	MYERS STEVEN S	-	Buy	$30.19K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q3	-	-

LSTA Ownership FAQ

Who Owns Lisata Therapeutics?

Lisata Therapeutics shareholders are primarily institutional investors at 7.84%, followed by 19.68% insiders and 72.48% retail investors. The average institutional ownership in Lisata Therapeutics's industry, Biotech Stocks , is 382.13%, which Lisata Therapeutics falls below.

Who owns the most shares of Lisata Therapeutics?

Lisata Therapeutics’s largest shareholders are Vanguard group (270.91K shares, 3.10%), Renaissance (123.72K shares, 1.42%), and Bml capital management (73.35K shares, 0.84%). Together, they hold 5.36% of Lisata Therapeutics’s total shares outstanding.

Does Blackrock own Lisata Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Lisata Therapeutics.

Who is Lisata Therapeutics’s biggest shareholder by percentage of total assets invested?

Bml capital management is Lisata Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.12% of its assets in 73.35K Lisata Therapeutics shares, valued at 136.43K$.

Who is the top mutual fund holder of Lisata Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Lisata Therapeutics shares, with 2.12% of its total shares outstanding invested in 191.37K Lisata Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools